Access SARS-CoV-2 IgM Antibody Test
By integrating a high-quality set of SARS-CoV-2-specific antibody tests into their routine workflow, laboratories of all sizes can give physicians greater clarity on patient immune response to the virus that causes COVID-19.
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
The Case for Separate Tests
When a total IgG and IgM assay is positive, it is unclear if the patient is currently infected or has an immune response to a prior infection.
This is because developed IgM is not sustained, while developed IgG can potentially be sustained longer, depending upon the infection and the individual.
In various studies, it has been seen that seroconversion for SARS-CoV-2 IgG and IgM may occur simultaneously or sequentially1. Thus, it’s important to identify both IgG and IgM individually. An IgM assay may provide information about current or recent infection; while IgG may signal a more sustained immune response.
A Menu that Matters
By integrating high-quality antibody tests into a routine workflow, laboratories of all sizes can offer physicians a set of tools to gain greater clarity on individuals who have antibodies to SARS-CoV-2 due to prior or recent viral infection.
High Sensitivity and Specificity
High sensitivity and specificity are key to providing physicians an accurate picture of patient immune response. Both the Access SARS-CoV-2 IgM and Access SARS-CoV-2 IgG tests have been validated against large, broad-based samples to ensure high quality.
Seamless Integration with Routine Lab Workflow
The Access SARS-CoV-2 IgM assay can be seamlessly integrated into current laboratory workflow without the need for batching or special maintenance. This can help your laboratory experience industry-leading system uptime.
